Hepatitis Delta Estimates in the United States Revisited

dc.contributor.author	Soriano, Vicente
dc.contributor.author	Gómez-Gallego, Felix
dc.contributor.author	Corral, Octavio Jorge
dc.date	2019-10-30
dc.date.accessioned	2020-03-02T08:20:31Z
dc.date.available	2020-03-02T08:20:31Z
dc.identifier.issn	15376591
dc.identifier.uri	https://reunir.unir.net/handle/123456789/9867
dc.description.abstract	To the Editor—We read with interest the article by Patel and colleagues [1], which reported an unexpected 33% prevalence of anti–hepatitis delta virus antibodies (anti-HDV-Abs) in a large and representative US household population. Estimates of 400 000 individuals with hepatitis delta in the United States could be drawn from the study. These figures are somewhat in line with recent claims of a global burden of up to 60 million people with hepatitis delta [2]. As highlighted by Patel et al [1], high-risk groups were not represented or were underrepresented in their survey of 16 143 US adults. Hepatitis delta is...	es_ES
dc.language.iso	eng	es_ES
dc.publisher	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America	es_ES
dc.relation.ispartofseries	;vol. 69, nº 10
dc.relation.uri	https://academic.oup.com/cid/article-abstract/69/10/1833/5426967?redirectedFrom=fulltext	es_ES
dc.rights	restrictedAccess	es_ES
dc.subject	Scopus	es_ES
dc.subject	JCR	es_ES
dc.title	Hepatitis Delta Estimates in the United States Revisited	es_ES
dc.type	Articulo Revista Indexada	es_ES
reunir.tag	~ARI	es_ES
dc.identifier.doi	https://doi.org/10.1093/cid/ciz271

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.